Get the Stockscreener App
2.46
3.80%
0.09
After Hours:
2.49
0.03
+1.22%
Codexis Inc stock is traded at $2.46, with a volume of 1.26M.
It is up +3.80% in the last 24 hours and up +52.80% over the past month.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.37
Open:
$2.37
24h Volume:
1.26M
Relative Volume:
0.59
Market Cap:
$223.54M
Revenue:
$70.39M
Net Income/Loss:
$-43.97M
P/E Ratio:
-4.7481
EPS:
-0.5181
Net Cash Flow:
$-23.85M
1W Performance:
+11.31%
1M Performance:
+52.80%
6M Performance:
-10.22%
1Y Performance:
+9.33%
1-Day Range:
$2.36
$2.485
1-Week Range:
$2.1501
$2.485
52-Week Range:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.46 | 215.36M | 70.39M | -43.97M | -23.85M | -0.5181 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Analyst sentiment unchanged after Codexis (CDXS) earnings - MSN
Integrated Millennium Group (CDXS) reports shared control of 4.73M shares - Stock Titan
Codexis Board Director Resignation and Governance Rebalancing Announced - TipRanks
Director changes and board class rebalance at Codexis (NASDAQ: CDXS) - Stock Titan
Codexis (NASDAQ:CDXS) Short Interest Drop Signals Nasdaq Composite Market Optimism - Kalkine Media
Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March - MarketBeat
537,833 Shares in Codexis, Inc. $CDXS Purchased by Tudor Investment Corp ET AL - MarketBeat
Treasury Yields: Is Codexis Inc stock technically oversold2026 Sector Moves & Smart Money Movement Tracker - baoquankhu1.vn
Codexis, Inc. (CDXS) Stock Price Today & Analysis - Gotrade
Aug PostEarnings: Is Codexis Inc stock technically oversold2026 Market Outlook & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
April 2026's Most Promising Penny Stocks - simplywall.st
Aberdeen Group plc Raises Stake in Codexis, Inc. $CDXS - MarketBeat
CDXS Stock Price, Quote & Chart | CODEXIS INC (NASDAQ:CDXS) - ChartMill
Codexis Faces Critical Commercialization Phase - AD HOC NEWS
CEO Moves: Should I invest in Codexis Inc before earningsPrice Action & Safe Entry Point Alerts - baoquankhu1.vn
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Vanguard disaggregates holdings; Codexis Inc (NASDAQ: CDXS) shows 0 shares - Stock Titan
Institution Moves: Will Codexis Inc benefit from rising consumer demandQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Analyst Sentiment Unchanged After Codexis (CDXS) Earnings - Insider Monkey
Codexis rises after Q4 beat, strong outlook - MSN
Benchmark reiterates Hold on Codexis stock after Q4 results By Investing.com - Investing.com India
Benchmark reiterates Hold on Codexis stock after Q4 results - Investing.com
Four Stocks at the Intersection of Enzymes, Longevity, and the $400 Billion Wellness Boom (CELV, NAGE, MTEX, CDXS) - marketscreener.com
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Biocatalysis Market Accelerates with Rising Demand - openPR.com
Jobs Data: Does Codexis Inc offer margin of safety2026 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
Fund Flows: Is Codexis Inc stock technically oversold2026 Chart Watch & Weekly High Return Stock Opportunities - baoquankhu1.vn
Biocatalysis and Biocatalysts Market is expected to Hit US$ 6.7 - openpr.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue GuidanceHas The Bull Case Changed? - simplywall.st
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2% - MarketBeat
Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance - Yahoo Finance
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):